2020
DOI: 10.1016/j.scr.2020.101952
|View full text |Cite
|
Sign up to set email alerts
|

Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
23
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(23 citation statements)
references
References 5 publications
0
23
0
Order By: Relevance
“…We introduced these mutations, using CRISPR/Cas9, into a well-characterized control iPSC line (K7-4Lf), obtained earlier from a clinically healthy individual 33 (Supplementary Table S2 ) and recovered 66 clones for the D91A variant and 124 clones for the G128R variant of which 6 (9.1%) and 4 (3.2%) clones, respectively, were positive for the target mutations. As a result, several clones with different SOD1 allelic variants were obtained (Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…We introduced these mutations, using CRISPR/Cas9, into a well-characterized control iPSC line (K7-4Lf), obtained earlier from a clinically healthy individual 33 (Supplementary Table S2 ) and recovered 66 clones for the D91A variant and 124 clones for the G128R variant of which 6 (9.1%) and 4 (3.2%) clones, respectively, were positive for the target mutations. As a result, several clones with different SOD1 allelic variants were obtained (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…IPSCs were dissociated with TrypLE (Gibco) and split at 1:10 twice a week in the iPSC medium supplemented with 10 ng/ml Y-27632. Original iPSC lines were derived from the patient (iALS) with a diagnosed hereditary form of ALS 37 and a healthy individual (K7-4Lf) who had no associations with any genetic disease 33 (Supplementary Table S2 ). The use of the iPSC lines, generated from the patients’ materials, in the study has been approved by the Research Ethics Committee of FSBI Federal Neurosurgical Center (Novosibirsk, Russia), protocol number 1 14/03/2017.…”
Section: Methodsmentioning
confidence: 99%
“…We introduced these mutations using CRISPR/Cas9, into a well-characterized control iPSC line (K7-4Lf), obtained earlier from a clinically healthy individual [30] (Supplementary Table 1) and recovered 66 clones for D91A variant and 124 clones for G128R variant. We screened those clones by tetra-primer ARMS PCR (for D91A) or qPCR with fluorescent probes (for G128R) and found 6 (9.1%) and 4 (3.2%) clones, respectively, presumably positive for the target mutations.…”
Section: Resultsmentioning
confidence: 99%
“…IPSC cells were dissociated with TrypLE (Gibco) and split at 1:10 twice a week in the iPSC medium supplemented with 10 ng/ml Y-27632. Original iPSC lines were derived from the patient (iALS) with a diagnosed hereditary form of ALS [29] and a healthy individual (K7-4Lf) who had no associations with any genetic disease [30] (Supplementary Table 1) .…”
Section: Methodsmentioning
confidence: 99%
“…G-banding karyotyping was performed at passage 8 of EC and SMC as previously described ( Malakhova et al, 2020 ). We analyzed 50 metaphase spreads using Nikon microscope TiE with Lucia Cytogenetics software.…”
Section: Methodsmentioning
confidence: 99%